Notes From the Field: Acquisition of Delamanid Under a Compassionate Use Program for Extensively Drug-Resistant Tuberculosis — United States, 2017

Details

• Journal Article:
  MMWR Morb Mortal Wkly Rep
• Personal Author:
  Lardizabal, Alfred A. ; Khan, Anum N. ; Bamrah Morris, Sapna ; Goswami, Neela D.
• Corporate Authors:
  National Center for HIV, Viral Hepatitis, STD, and TB Prevention (U.S.)Division of Tuberculosis Elimination.
• Subjects:
  Antitubercular Agents Compassionate Use Trials Extensively Drug-Resistant Tuberculosis Health Services Accessibility Humans Nitroimidazoles Notes From The Field Oxazoles
• Source:
  MMWR: Morbidity and Mortality Weekly Report 2018; v. 67, no. 35
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm6735a6
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  30188880
• Pubmed Central ID:
  PMC6132180
• Document Type:
  Journal Article
• Name as Subject:
  Centers for Disease Control and Prevention (U.S.)
• Place as Subject:
  United States
• Pages in Document:
  p. 996-997
• Volume:
  67
• Issue:
  35
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:1542aa2ab064213abc790958b616a3c678675ffb294f733f5e49069de3423bc6e92f5e88a81a60c12b765e43a9f02773bbf04ec455d8879df9e7ce5397853c55
• Download URL:
  https://stacks.cdc.gov/view/cdc/59349/cdc_59349_DS1.pdf
• File Type:
  [PDF - 131.78 KB ]